{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T11:39:40Z","timestamp":1775561980088,"version":"3.50.1"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"suppl_3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1093\/infdis\/jir332","type":"journal-article","created":{"date-parts":[[2011,10,10]],"date-time":"2011-10-10T22:54:28Z","timestamp":1318287268000},"page":"S1032-S1042","source":"Crossref","is-referenced-by-count":41,"title":["Impact of Systemic or Mucosal Immunity to Adenovirus on Ad-Based Ebola Virus Vaccine Efficacy in Guinea Pigs"],"prefix":"10.1093","volume":"204","author":[{"given":"Jason S.","family":"Richardson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max C.","family":"Abou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaylie N.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anand","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beni M.","family":"Sahai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary P.","family":"Kobinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2011,11,1]]},"reference":[{"key":"key\n\t\t\t\t20170702134221_bib1","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1007\/PL00000821","article-title":"Ebola virus: the search for vaccines and treatments","volume":"58","author":"Wilson","year":"2001","journal-title":"Cell Mol Life Sci"},{"key":"key\n\t\t\t\t20170702134221_bib2","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1001\/jama.287.18.2391","article-title":"Hemorrhagic fever viruses as biological weapons: medical and public health management","volume":"287","author":"Borio","year":"2002","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170702134221_bib3","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1016\/j.vaccine.2004.11.070","article-title":"Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections","volume":"23","author":"Swenson","year":"2005","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170702134221_bib4","doi-asserted-by":"crossref","first-page":"15889","DOI":"10.1073\/pnas.2237038100","article-title":"Ebola virus-like particles protect from lethal Ebola virus infection","volume":"100","author":"Warfield","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20170702134221_bib5","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.4049\/jimmunol.175.2.1184","article-title":"Induction of humoral and CD8+ T cell responses are required for protection against lethal Ebola virus infection","volume":"175","author":"Warfield","year":"2005","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20170702134221_bib6","doi-asserted-by":"crossref","first-page":"S430","DOI":"10.1086\/520583","article-title":"Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge","volume":"196","author":"Warfield","year":"2007","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170702134221_bib7","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1371\/journal.ppat.0030002","article-title":"Effective post-exposure treatment of Ebola infection","volume":"3","author":"Feldmann","year":"2007","journal-title":"PLoS Pathog"},{"key":"key\n\t\t\t\t20170702134221_bib8","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1128\/JVI.78.10.5458-5465.2004","article-title":"Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses","volume":"78","author":"Garbutt","year":"2004","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20170702134221_bib9","doi-asserted-by":"crossref","first-page":"7296","DOI":"10.1128\/JVI.00561-09","article-title":"Single-injection vaccine protects nonhuman primates against infection with Marburg virus and three species of Ebola virus","volume":"83","author":"Geisbert","year":"2009","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20170702134221_bib10","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nm1258","article-title":"Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses","volume":"11","author":"Jones","year":"2005","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20170702134221_bib11","doi-asserted-by":"crossref","first-page":"e5547","DOI":"10.1371\/journal.pone.0005547","article-title":"Mucosal immunization of cynomolgus macaques with the VSVDeltaG\/ZEBOVGP vaccine stimulates strong Ebola GP-specific immune responses","volume":"4","author":"Qiu","year":"2009","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170702134221_bib12","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.1128\/JVI.00105-07","article-title":"Successful topical respiratory tract immunization of primates against Ebola virus","volume":"81","author":"Bukreyev","year":"2007","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20170702134221_bib13","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1128\/JVI.80.5.2267-2279.2006","article-title":"A single intranasal inoculation with a paramyxovirus-vectored vaccine protects guinea pigs against a lethal-dose Ebola virus challenge","volume":"80","author":"Bukreyev","year":"2006","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20170702134221_bib14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.virol.2008.04.029","article-title":"A paramyxovirus-vectored intranasal vaccine against Ebola virus is immunogenic in vector-immune animals","volume":"377","author":"Yang","year":"2008","journal-title":"Virology"},{"key":"key\n\t\t\t\t20170702134221_bib15","doi-asserted-by":"crossref","first-page":"e3548","DOI":"10.1371\/journal.pone.0003548","article-title":"Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice","volume":"3","author":"Croyle","year":"2008","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170702134221_bib16","doi-asserted-by":"crossref","first-page":"S413","DOI":"10.1086\/520603","article-title":"Mucosal delivery of adenovirus-based vaccine protects against Ebola virus infection in mice","volume":"196","author":"Patel","year":"2007","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170702134221_bib17","doi-asserted-by":"crossref","first-page":"e5308","DOI":"10.1371\/journal.pone.0005308","article-title":"Enhanced protection against Ebola virus mediated by an improved adenovirus-based vaccine","volume":"4","author":"Richardson","year":"2009","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170702134221_bib18","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1371\/journal.pmed.0030177","article-title":"Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs","volume":"3","author":"Sullivan","year":"2006","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t20170702134221_bib19","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/35046108","article-title":"Development of a preventive vaccine for Ebola virus infection in primates","volume":"408","author":"Sullivan","year":"2000","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170702134221_bib20","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2310\/6650.2005.53605","article-title":"Innate immune response to adenovirus","volume":"53","author":"Nazir","year":"2005","journal-title":"J Investig Med"},{"key":"key\n\t\t\t\t20170702134221_bib21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1089\/hum.2005.16.157","article-title":"Adenovirus-based genetic vaccines for biodefense","volume":"16","author":"Boyer","year":"2005","journal-title":"Hum Gene Ther"},{"key":"key\n\t\t\t\t20170702134221_bib22","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1586\/14760584.6.2.255","article-title":"Use of viral vectors for the development of vaccines","volume":"6","author":"Liniger","year":"2007","journal-title":"Expert Rev Vaccines"},{"key":"key\n\t\t\t\t20170702134221_bib23","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1128\/CVI.00162-06","article-title":"A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial","volume":"13","author":"Martin","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"key\n\t\t\t\t20170702134221_bib24","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1128\/JVI.02696-06","article-title":"Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D","volume":"81","author":"Abbink","year":"2007","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20170702134221_bib25","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1128\/CDLI.11.2.351-357.2004","article-title":"Prevalence of neutralizing antibodies to adenoviral serotypes 5 and 35 in the adult populations of the Gambia, South Africa, and the United States","volume":"11","author":"Nwanegbo","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"key":"key\n\t\t\t\t20170702134221_bib26","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1038\/sj.gt.3302619","article-title":"Adenovirus as vehicle for anticancer genetic immunotherapy","volume":"12","author":"Gallo","year":"2005","journal-title":"Gene Ther"},{"key":"key\n\t\t\t\t20170702134221_bib27","doi-asserted-by":"crossref","first-page":"14161","DOI":"10.1128\/JVI.79.22.14161-14168.2005","article-title":"Immunogenicity of recombinant fiber-chimeric adenovirus serotype 35 vector-based vaccines in mice and rhesus monkeys","volume":"79","author":"Nanda","year":"2005","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20170702134221_bib28","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1128\/JVI.80.4.1688-1699.2006","article-title":"A novel adenovirus type 6 (Ad6)-based hepatitis C virus vector that overcomes preexisting anti-ad5 immunity and induces potent and broad cellular immune responses in rhesus macaques","volume":"80","author":"Capone","year":"2006","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20170702134221_bib29","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.virol.2005.10.042","article-title":"Chimpanzee adenovirus vaccine protects against Zaire ebola virus","volume":"346","author":"Kobinger","year":"2006","journal-title":"Virology"},{"key":"key\n\t\t\t\t20170702134221_bib30","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/mt.2008.12","article-title":"Bovine adenoviral vector-based H5N1 influenza vaccine overcomes exceptionally high levels of preexisting immunity against human adenovirus","volume":"16","author":"Singh","year":"2008","journal-title":"Mol Ther"},{"key":"key\n\t\t\t\t20170702134221_bib31","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1089\/10430349950018021","article-title":"PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo","volume":"10","author":"O\u2019Riordan","year":"1999","journal-title":"Hum Gene Ther"},{"key":"key\n\t\t\t\t20170702134221_bib32","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1089\/104303402760372972","article-title":"PEGylation of E1-deleted adenovirus vectors allows significant gene expression on readministration to liver","volume":"13","author":"Croyle","year":"2002","journal-title":"Hum Gene Ther"},{"key":"key\n\t\t\t\t20170702134221_bib33","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/sj.gt.3302441","article-title":"PEGylated helper-dependent adenoviral vectors: highly efficient vectors with an enhanced safety profile","volume":"12","author":"Croyle","year":"2005","journal-title":"Gene Ther"},{"key":"key\n\t\t\t\t20170702134221_bib34","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/jgm.699","article-title":"PEGylated adenovirus vectors containing RGD peptides on the tip of PEG show high transduction efficiency and antibody evasion ability","volume":"7","author":"Eto","year":"2005","journal-title":"J Gene Med"},{"key":"key\n\t\t\t\t20170702134221_bib35","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.virol.2005.09.057","article-title":"New viral vaccines","volume":"344","author":"Arvin","year":"2006","journal-title":"Virology"},{"key":"key\n\t\t\t\t20170702134221_bib36","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.4049\/jimmunol.170.11.5636","article-title":"Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen","volume":"170","author":"Boyaka","year":"2003","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20170702134221_bib37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-1-4419-8993-2_4","article-title":"Mucosal immunity to infections and its importance in future vaccinology","volume":"549","author":"Lajeunesse","year":"2004","journal-title":"Adv Exp Med Biol"},{"key":"key\n\t\t\t\t20170702134221_bib38","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/S0264-410X(03)00195-6","article-title":"Innate immunity and pathogen-host interaction","volume":"21","author":"Basset","year":"2003","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170702134221_bib39","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1517\/14712598.6.1.63","article-title":"Therapeutic potential of adenovirus as a vaccine vector for chronic virus infections","volume":"6","author":"Zhou","year":"2006","journal-title":"Expert Opin Biol Ther"},{"key":"key\n\t\t\t\t20170702134221_bib40","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nature01876","article-title":"Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates","volume":"424","author":"Sullivan","year":"2003","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170702134221_bib41","doi-asserted-by":"crossref","first-page":"S203","DOI":"10.1086\/514305","article-title":"Pathogenesis of experimental Ebola virus infection in guinea pigs","volume":"179","author":"Connolly","year":"1999","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170702134221_bib42","doi-asserted-by":"crossref","first-page":"7260","DOI":"10.1128\/JVI.00051-06","article-title":"Infection of naive target cells with virus-like particles: implications for the function of Ebola virus VP24","volume":"80","author":"Hoenen","year":"2006","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20170702134221_bib43","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1128\/CVI.00170-10","article-title":"Enzyme-linked immunosorbent assay for the detection of filovirus species-specific antibodies","volume":"17","author":"Nakayama","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"key\n\t\t\t\t20170702134221_bib44","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nri2098","article-title":"How Ebola and Marburg viruses battle the immune system","volume":"7","author":"Mohamadzadeh","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"key\n\t\t\t\t20170702134221_bib45","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nri1439","article-title":"NALT- versus Peyer\u2019s-patch-mediated mucosal immunity","volume":"4","author":"Kiyono","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"key\n\t\t\t\t20170702134221_bib46","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1146\/annurev.immunol.24.021605.090650","article-title":"Intestinal and pulmonary mucosal T cells: local heroes fight to maintain the status quo","volume":"24","author":"Lefrancois","year":"2006","journal-title":"Annu Rev Immunol"},{"key":"key\n\t\t\t\t20170702134221_bib47","doi-asserted-by":"crossref","first-page":"10780","DOI":"10.1128\/JVI.77.20.10780-10789.2003","article-title":"Oral vaccination of mice with adenoviral vectors is not impaired by preexisting immunity to the vaccine carrier","volume":"77","author":"Xiang","year":"2003","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20170702134221_bib48","doi-asserted-by":"crossref","first-page":"6885","DOI":"10.1128\/IAI.73.10.6885-6891.2005","article-title":"Induction of protective immunity to anthrax lethal toxin with a nonhuman primate adenovirus-based vaccine in the presence of preexisting anti-human adenovirus immunity","volume":"73","author":"Hashimoto","year":"2005","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20170702134221_bib49","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/vim.2005.18.283","article-title":"Adenoviral vectors for mucosal vaccination against infectious diseases","volume":"18","author":"Santosuosso","year":"2005","journal-title":"Viral Immunol"},{"key":"key\n\t\t\t\t20170702134221_bib50","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.ymthe.2006.03.027","article-title":"A chimpanzee-origin adenovirus vector expressing the rabies virus glycoprotein as an oral vaccine against inhalation infection with rabies virus","volume":"14","author":"Zhou","year":"2006","journal-title":"Mol Ther"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/204\/suppl_3\/S1032\/18082958\/jir332.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T20:23:05Z","timestamp":1593116585000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article-lookup\/doi\/10.1093\/infdis\/jir332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":50,"journal-issue":{"issue":"suppl_3","published-online":{"date-parts":[[2011,11,1]]},"published-print":{"date-parts":[[2011,11]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jir332","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}